Richwood Investment Advisors LLC Sells 265 Shares of Colgate-Palmolive (NYSE:CL)

Richwood Investment Advisors LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 3,897 shares of the company’s stock after selling 265 shares during the quarter. Richwood Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $354,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Chicago Partners Investment Group LLC lifted its stake in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares during the period. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at about $1,315,000. Fiduciary Alliance LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at about $4,066,000. Impact Partnership Wealth LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $803,000. Finally, Barclays PLC increased its position in shares of Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.0 %

CL stock opened at $90.30 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market capitalization of $73.28 billion, a price-to-earnings ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The business has a 50 day simple moving average of $89.33 and a two-hundred day simple moving average of $94.18.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive declared that its board has authorized a share repurchase plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Wall Street Analysts Forecast Growth

CL has been the subject of several research reports. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.